UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 27

Sortiert nach

Eight versus twelve weeks of sofosbuvir-velpatasvir in treatment-naïve non-cirrhotic patients with chronic hepatitis C virus infection: Study protocol for a multicentric, open labelled, randomized, non-inferiority trial (RESOLVE trial)

PloS one, 2023-05, Vol.18 (5), p.e0285725-e0285725

2023

Volltextzugriff (PDF)

The Antiviral Activity of Interferon-Induced Transmembrane Proteins and Virus Evasion Strategies

Viruses, 2024-05, Vol.16 (5), p.734

2024

Volltextzugriff (PDF)

Serological Immune Response Following ChAdOx1 nCoV-19 Vaccine (Covishield ® ) in Patients with Liver Cirrhosis

Vaccines (Basel), 2022-10, Vol.10 (11), p.1837

2022

Volltextzugriff (PDF)

Durability of ChAdOx1 nCoV-19 (Covishield ® ) Vaccine Induced Antibody Response in Health Care Workers

Vaccines (Basel), 2022-12, Vol.11 (1), p.84

2022

Volltextzugriff (PDF)

Antibody Response to ChAdOx1 nCoV-19 (AZD1222) Vaccine in Kidney Transplant Recipients

Vaccines (Basel), 2022-10, Vol.10 (10), p.1693

2022

Volltextzugriff (PDF)

Prevalence of hepatitis E viraemia among blood donors: a systematic review

Vox sanguinis, 2020-04, Vol.115 (3), p.120-132

2020

Volltextzugriff (PDF)

Use of Sofosbuvir/Velpatasvir/Voxilaprevir for Sofosbuvir Nonresponder Genotype 3 HCV Infection in India

Journal of clinical and experimental hepatology, 2022-03, Vol.12 (2), p.669-671

2022

Volltextzugriff (PDF)

Profile of bacterial infections in patients with acute on chronic liver failure admitted to Intensive Care Unit and its impact on the patient outcomes

Journal of clinical and experimental hepatology, 2024, Vol.14, p.102103, Article 102103

2024

Volltextzugriff (PDF)

Temporal profile of HEV RNA concentration in blood and stool from patients with acute uncomplicated hepatitis E in a region with genotype 1 predominance

Journal of viral hepatitis, 2020-06, Vol.27 (6), p.631-637

2020

Volltextzugriff (PDF)

Humoral and cellular immune response in patients of liver cirrhosis and immunocompetent recipient of ChAdOx1nCoV-19 Vaccine (Covishield)

Clinical and experimental medicine, 2024-01, Vol.24 (1), p.24-24, Article 24

2024

Volltextzugriff (PDF)

Profile of patients who failed to achieve sustained virological response with sofosbuvir containing first line antiviral therapy in India

Journal of clinical and experimental hepatology, 2024, Vol.14, p.102305, Article 102305

2024

Volltextzugriff (PDF)

Antibody response to ChAdOx1 nCoV-19 (Covishield®) vaccine in people on maintenance hemodialysis

Seminars in dialysis, 2023-11, Vol.36 (6), p.477-482

2023

Volltextzugriff (PDF)

Hepatitis C Retreatment With First-Line Direct Acting Antiviral Drugs

Journal of clinical and experimental hepatology, 2023-09, Vol.13 (5), p.736-741

2023

Volltextzugriff (PDF)

Serum Bile Acid Levels in Women With Intrahepatic Cholestasis of Pregnancy in India

Journal of clinical and experimental hepatology, 2022-03, Vol.12 (2), p.379-383

2022

Volltextzugriff (PDF)

Prevalence of hepatitis E virus viremia and antibodies among healthy blood donors in India

Indian journal of gastroenterology, 2018-07, Vol.37 (4), p.342-346

2018

Volltextzugriff (PDF)

Rescue use of Pegylated Interferon in Dialysis Patient who Failed to Respond Sofosbuvir

Indian journal of nephrology, 2023-03, Vol.33 (2), p.152-154

2023

Volltextzugriff (PDF)

Serum Bile Acid Levels in Women with Intrahepatic Cholestasis of Pregnancy in India

Journal of clinical and experimental hepatology, 2022, Vol.12, p.S32-S33

2022

Volltextzugriff (PDF)

Hepatitis C re-treatment with first line direct acting antiviral drugs

Journal of clinical and experimental hepatology, 2022, Vol.12, p.S88-S88

2022

Volltextzugriff (PDF)

Blood transfusion and surgery as a screening tool screening for HCV infection in the Indian population

Journal of clinical and experimental hepatology, 2023, Vol.13, p.S88-S88

2023

Volltextzugriff (PDF)

Genotyping of hepatitis B virus isolates from Lahaul and Spiti district in Himachal Pradesh, India

Indian journal of gastroenterology, 2018-05, Vol.37 (3), p.261-265

2018

Volltextzugriff (PDF)

Sofosbuvir/Velpatasvir/Voxilaprevir for HCV Retreatment In Difficult To Treat Patients Who Failed With First-Line Direct Acting Antivirals: A Real-Life Data From India

Journal of clinical and experimental hepatology, 2023, Vol.13, p.S93-S94

2023

Volltextzugriff (PDF)

Blood transfusion is unlikely to be a source for hepatitis E virus transmission in India

Indian journal of gastroenterology, 2020-04, Vol.39 (2), p.161-164

2020

Volltextzugriff (PDF)

Sofosbuvir/Velpatasvir/Voxilaprevir for Hepatitis C Virus Retreatment in Difficult-to-treat Patients: A Real-life Observational Study from India

Journal of clinical and experimental hepatology, 2024-03, Vol.14 (2), p.101314-101314, Article 101314

2024

Volltextzugriff (PDF)

Serological immune response following ChAdOx1 nCoV-19 vaccine (Covishield) in patients with liver cirrhosis

Journal of clinical and experimental hepatology, 2022, Vol.12, p.S44-S45

2022

Volltextzugriff (PDF)

6. Prevalence of hepatitis E virus viremia and antibodies among healthy blood donors in India

Journal of clinical and experimental hepatology, 2018-07, Vol.8, p.S15-S15

2018

Volltextzugriff (PDF)

1 – 25 von 27

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(25)
Mit Volltextzugriff
(27)

Publikationsform

Artikel
(26)
Berichte
(1)

Sprache

Englisch
(27)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Eight versus twelve weeks of sofosbuvir-velpatasvir in treatment-naïve non-cirrhotic patients with chronic hepatitis C virus infection: Study protocol for a multicentric, open labelled, randomized, non-inferiority trial (RESOLVE trial)

The Antiviral Activity of Interferon-Induced Transmembrane Proteins and Virus Evasion Strategies

Serological Immune Response Following ChAdOx1 nCoV-19 Vaccine (Covishield ® ) in Patients with Liver Cirrhosis

Durability of ChAdOx1 nCoV-19 (Covishield ® ) Vaccine Induced Antibody Response in Health Care Workers

Antibody Response to ChAdOx1 nCoV-19 (AZD1222) Vaccine in Kidney Transplant Recipients

Prevalence of hepatitis E viraemia among blood donors: a systematic review

Use of Sofosbuvir/Velpatasvir/Voxilaprevir for Sofosbuvir Nonresponder Genotype 3 HCV Infection in India

Profile of bacterial infections in patients with acute on chronic liver failure admitted to Intensive Care Unit and its impact on the patient outcomes

Temporal profile of HEV RNA concentration in blood and stool from patients with acute uncomplicated hepatitis E in a region with genotype 1 predominance

Humoral and cellular immune response in patients of liver cirrhosis and immunocompetent recipient of ChAdOx1nCoV-19 Vaccine (Covishield)

Profile of patients who failed to achieve sustained virological response with sofosbuvir containing first line antiviral therapy in India

Antibody response to ChAdOx1 nCoV-19 (Covishield®) vaccine in people on maintenance hemodialysis

Hepatitis C Retreatment With First-Line Direct Acting Antiviral Drugs

Serum Bile Acid Levels in Women With Intrahepatic Cholestasis of Pregnancy in India

Prevalence of hepatitis E virus viremia and antibodies among healthy blood donors in India

Rescue use of Pegylated Interferon in Dialysis Patient who Failed to Respond Sofosbuvir

Serum Bile Acid Levels in Women with Intrahepatic Cholestasis of Pregnancy in India

Hepatitis C re-treatment with first line direct acting antiviral drugs

Blood transfusion and surgery as a screening tool screening for HCV infection in the Indian population

Genotyping of hepatitis B virus isolates from Lahaul and Spiti district in Himachal Pradesh, India

Sofosbuvir/Velpatasvir/Voxilaprevir for HCV Retreatment In Difficult To Treat Patients Who Failed With First-Line Direct Acting Antivirals: A Real-Life Data From India

Blood transfusion is unlikely to be a source for hepatitis E virus transmission in India

Sofosbuvir/Velpatasvir/Voxilaprevir for Hepatitis C Virus Retreatment in Difficult-to-treat Patients: A Real-life Observational Study from India

Serological immune response following ChAdOx1 nCoV-19 vaccine (Covishield) in patients with liver cirrhosis

6. Prevalence of hepatitis E virus viremia and antibodies among healthy blood donors in India

Suchergebnisse filtern